PR Newswire is a global leader in communications and marketing services, enabling organizations to connect and engage with their target audiences worldwide.
Recent Articles By The Author
Axiom Foods Awarded First 'Method Of Use' Patent For Oryzatein® Rice Protein
Licensing Opportunities Offered to Manufacturers to Use Clinically Studied Claims
Goodyear Celebrates 35 Years Of Highway Heroes
Finalists for prestigious trucking industry award announced
As Lilly Deals With Yet Another Set-Back In Entering The US Rheumatoid Arthritis Market, Pfizer's Xeljanz Further Solidifies Its Position As A Go-To Alternate Mechanism Of Action Agent, According To A Recently Published Study By Spherix Global Insights
Though baricitinib (Olumiant) has been resubmitted for FDA approval, time lost on the US market has opened up doors for Xeljanz